Vascular Tone Monitoring System (VATMOS)
Value Proposition
By continuously assessing peripheral vascular tone, this piezoelectric-optical wearable ring provides real time insights into how the cardiovascular system is responding to illness or injury before changes in traditional vital signs like blood pressure occur. This sensor provides almost immediate feedback to clinicians on the physiologic response to treatment.
Competitive Advantage
VATMOS is easily portable, provides continuous hemodynamic monitoring, and predicts hypotension up to 108 minutes in advance. VATMOS also provides more relevant data to physicians, making it a better indicator of patient physiology than current devices such as pulse oximeters. VATMOS has practical applications in dialysis centers, combat situations, emergency rooms, ambulances, and eventually in a patient’s home.
Continuous Monitoring
Portable
Numerous Applications
Unique Features
VATMOS is easily portable
VATMOS can detect potential cardiovascular events and hypotension much earlier than the traditional cuff system
VATMOS provides continuous hemodynamic monitoring, and predicts hypotension up to 108 minutes in advance
Better indicator of patient physiology than current devices such as pulse oximeters
Licensing Information
New Vital Signs in 2017
Principal Investigators
Sardar Anari, PhD
Kevin Ward, MD
Kayvan Najarian, PhD
Kenn Oldham, PhD
Intellectual Property
Invention Disclosure #5949, 6147, 7169, 2020-205
Patent Issued Patent Issued # US10610113, US9974488, US11172839.
Solution Sheet
Download Solution Sheet (PDF)
Image courtesy of project team
In many emergency and critical care situations, having an accurate read on a patient’s autoregulatory response is vital for a successful outcome. VATMOS provides a cardiovascular vital sign for at risk patients in settings like sepsis, trauma, complex cardiovascular surgeries, and TBI. VATMOS also has practical applications in dialysis centers, combat situations, emergency rooms, ambulances, and eventually in a patient’s home.
Contact New Vital Signs for more information about investment and partnership opportunities.
Funding History
$586,335 in non-dilutive funding
• 2016 $121,000 Coulter Foundation • 2016 $374,999 NSF • 2017 $85,000 The Michigan Institute for Clinical & Health Research (MICHR)
• 2018 $5,336 Frankel Cardiovascular Center Micro Grant Award • Substantial additional departmental, school and center based support
Funding Organizations
